Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.01M | -20.38M | 16.91M | 32.30M | 14.40M |
| Total Depreciation and Amortization | 15.43M | 15.41M | 15.46M | 14.89M | 14.70M |
| Total Amortization of Deferred Charges | 248.00K | 248.00K | 248.00K | 247.00K | 248.00K |
| Total Other Non-Cash Items | -29.97M | 49.42M | 6.16M | 11.56M | 9.94M |
| Change in Net Operating Assets | -50.41M | 25.58M | 66.85M | -6.70M | -45.83M |
| Cash from Operations | -3.69M | 70.28M | 105.62M | 52.31M | -6.54M |
| Capital Expenditure | -1.22M | -1.11M | -1.39M | -1.39M | -2.67M |
| Sale of Property, Plant, and Equipment | 15.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -174.00K | -170.00K | -1.06M | -186.00K | -398.00K |
| Cash from Investing | -1.37M | -1.28M | -2.45M | -1.57M | -3.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.74M | -9.63M | -9.35M | -9.44M | -8.94M |
| Issuance of Common Stock | 93.00K | 221.00K | 88.00K | -- | -- |
| Repurchase of Common Stock | -2.86M | -1.31M | -645.00K | -3.58M | -617.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -785.00K | -487.00K | -5.18M | -1.06M | 1.01M |
| Cash from Financing | -13.30M | -11.21M | -15.09M | -14.08M | -8.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.36M | 57.79M | 88.09M | 36.65M | -18.16M |